Apellis Pharmaceuticals, Inc. (APLS) Insider Trading

Name: Apellis Pharmaceuticals, Inc. (APLS) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (May 14, 2026): Dunlop A. Sinclair (Director): Tender of Shares of 161,567 shares.

Get alerted when insiders trade APLS

Email address

Loading company data...

Loading company details...